MedImpact issued an updated bulletin to pharmacies clarifying the coverage limits on naloxone 4 mg nasal spray. This applies to both brand and generic covered NDCs.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
MedImpact issued an updated bulletin to pharmacies clarifying the coverage limits on naloxone 4 mg nasal spray. This applies to both brand and generic covered NDCs.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.